Diabetic Retinopathy Screening Solutions

Support efficient diabetic retinopathy screening with portable fundus cameras, AI-assisted image analysis and integrated screening workflow management.

Contact us
Diabetic retinopathy screening

Flexible Screening Services Across Healthcare Settings

Optomed solutions enable healthcare organizations to deliver diabetic retinopathy screening across different clinical environments and locations.

Portable retinal imaging, AI-assisted detection and screening management software support efficient screening services, whether examinations are performed at a single clinic, across multiple healthcare facilities or through mobile screening programs.

OUR SOLUTIONS SUPPORT RETINAL SCREENING

From Individual Clinics to Large-Scale Screening Programs

Eye clinics​

Hospitals

Mobile Screening​​

Screening Programs

AI-Powered Diabetic Retinopathy Detection​​

AI-powered retinal screening can support image assessment and help healthcare providers manage growing screening volumes while maintaining consistent screening processes.

In a clinical study*, Optomed Aurora handheld fundus camera images analyzed with Aireen AI demonstrated 94.8% sensitivity, 91.4% specificity and 92.7% diagnostic accuracy for diabetic retinopathy detection.

Combined with portable retinal imaging, AI-powered screening can support efficient workflows in different healthcare settings, from individual screening clinics to large-scale screening programs.

*Huhtinen P, et al. 2025 Diabetes Technol Ther. doi:10.1177/15209156251369886

Optomed Lumo Portable Fundus Camera

Portability Without Compromising Image Quality​

Optomed’s handheld fundus cameras combine high-quality retinal imaging with portability and ease of use, enabling screening across different healthcare environments.

Our new flagship product, Optomed Lumo, features intuitive user guidance, automated imaging functions and a touch screen interface. Its flexible handheld and desktop operation makes it suitable for various screening workflows.

Optomed Aurora IQ provides high-quality retinal imaging in a compact handheld format. Aurora AEYE is the first FDA-cleared handheld AI fundus camera for autonomous diabetic retinopathy detection in the United States.​

Clinical studies show that Optomed’s handheld fundus cameras provide image quality comparable to conventional tabletop fundus cameras for diabetic retinopathy screening.

Explore Optomed Fundus Cameras

Streamline Large-Scale Screening with Avenue Eye Screen​

Managing a screening program requires more than retinal image acquisition. It is a complete process from patient invitations to follow-up and reporting.

Avenue Eye Screen is a comprehensive workflow management system designed to automate and streamline diabetic retinopathy screening programs.

The software supports the complete screening process, including patient enrollment, call and recall, examination results, follow-up management and screening statistics.

Avenue Eye Screen can integrate with existing patient information systems and other hospital systems, supporting efficient information flow across screening services.

Learn more about Avenue Eye Screen


CONTACT US

Looking for a Diabetic Retinopathy Screening Solution?

.

    I have read Optomed's Privacy Statement and I accept the policy.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.